ENDLOS-TURBO PUT - AMGEN | Market Closed - Deutsche Boerse AG 15:35:24 2024-05-31 EDT | ||
| 4.44 EUR | -3.27% |
|
| 1 month | -40.08% | ||
| 3 months | -37.64% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 4.44 | -3.27% |
| 24-05-30 | 4.59 | -11.22% |
| 24-05-29 | 5.17 | +6.38% |
| 24-05-28 | 4.86 | +21.20% |
| 24-05-27 | 4.01 | -5.87% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 03:35 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ258D |
| ISIN | DE000DJ258D5 |
| Date issued | 2023-10-13 |
| Strike | 351.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.677 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.96 € |
|---|---|
| Lowest since issue | 2.56 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
